Pasithea Therapeutics Corp's total assets for Q4 2024 were $16.06M, a decrease of -13.80% from the previous quarter. KTTA total liabilities were $1.28M for the fiscal quarter, a 55.59% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.